3ao3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase== | |||
<StructureSection load='3ao3' size='340' side='right'caption='[[3ao3]], [[Resolution|resolution]] 1.90Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[3ao3]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AO3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3AO3 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> | |||
== | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMC:3-(1,3-BENZODIOXOL-5-YL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC+ACID'>BMC</scene>, <scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
[[3ao3]] is a 2 chain structure with sequence from [ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ao3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ao3 OCA], [https://pdbe.org/3ao3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ao3 RCSB], [https://www.ebi.ac.uk/pdbsum/3ao3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ao3 ProSAT]</span></td></tr> | ||
</table> | |||
== | == Function == | ||
< | [https://www.uniprot.org/uniprot/Q72498_9HIV1 Q72498_9HIV1] | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: | [[Category: Chalmers DK]] | ||
[[Category: | [[Category: Headey SJ]] | ||
[[Category: | [[Category: Parker MW]] | ||
[[Category: | [[Category: Scanlon MJ]] | ||
[[Category: | [[Category: Wielens J]] | ||
Latest revision as of 18:50, 4 October 2023
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integraseFragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase
Structural highlights
Function |
|